Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 61 (4) , 1199-1209
- https://doi.org/10.1046/j.1523-1755.2002.00249.x
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- Abnormalities of endothelial function in patients with predialysis renal failureHeart, 2000
- Future for folates in cardiovascular diseaseEuropean Journal of Clinical Investigation, 1999
- Low Whole-Blood S -Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patientsAtherosclerosis, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Serum Folate and Risk for Ischemic StrokeStroke, 1995
- Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementationAtherosclerosis, 1995
- Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysisThe Journal of Nutritional Biochemistry, 1994
- Vitamin Levels in Chronic Renal Failure and Need for SupplementationBlood Purification, 1985